Human papillomavirus (HPV) is known to be a necessary factor for many gynecologic
malignancies and is also associated with a subset of head and neck malignancies. This …

Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …

Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide.
Early prevention with HPV vaccination is a safe and effective method against this disease …

Human papillomavirus (HPV), the most common sexually transmitted virus, and its
associated diseases continue to cause significant morbidity and mortality in over 600 million …

Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and
head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer …

Background Human papillomavirus (HPV) infections and associated diseases remain a
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …

It has been more than 10 years that the first prophylactic papillomavirus vaccine became
available, although distribution has been mainly limited to the more affluent countries. The …

Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …

High-risk types of human papillomavirus (HPV) cause over 500,000 cervical, anogenital and
oropharyngeal cancer cases per year. The transforming potential of HPVs is mediated by …

Persistent human papillomavirus (HPV) is the primary etiologic agent of cervical cancer and
causes a significant number of vulvar, penile, anal and oropharyngeal cancers. The …